Literature DB >> 1969282

Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion.

V J Teeuwsen1, K H Siebelink, F de Wolf, J Goudsmit, F G UytdeHaag, A D Osterhaus.   

Abstract

In a previous study we have shown that peripheral blood mononuclear cells (PBMC) from asymptomatic HIV-seropositive male homosexuals, who had seroconverted more than 2 years before, were unable to mount a secondary immune response in vitro to certain viral and bacterial antigens. We have extended this study by investigating the secondary immune responses of five male homosexuals, who, by regular screening, were found to have seroconverted for HIV-1 during the preceding 3 months and were subsequently vaccinated with tetanus toxoid and poliovirus vaccine. Six weeks after the booster vaccination, PBMC of the five recently seroconverted individuals were assayed for in vitro mitogen or recall antigen-induced antibody synthesis and lymphocyte proliferation. The results of this study indicate that certain of the in vitro abnormalities of immune reactions, observed in both symptomatic and asymptomatic HIV-seropositive individuals, can already be found within 3 months after seroconversion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969282     DOI: 10.1097/00002030-199001000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

Authors:  Biswanath Majumder; Michelle L Janket; Elizabeth A Schafer; Keri Schaubert; Xiao-Li Huang; June Kan-Mitchell; Charles R Rinaldo; Velpandi Ayyavoo
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 2.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

3.  HIV-induced deletion of antigen-specific T cell function is MHC restricted.

Authors:  F Manca; A Newell; M Valle; J Habeshaw; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

Review 4.  Lymphocyte subsets as surrogate markers in antiretroviral therapy.

Authors:  J R Bogner; F D Goebel
Journal:  Infection       Date:  1991       Impact factor: 3.553

5.  Identification of protein kinases dysregulated in CD4(+) T cells in pathogenic versus apathogenic simian immunodeficiency virus infection.

Authors:  P Bostik; P Wu; G L Dodd; F Villinger; A E Mayne; V Bostik; B D Grimm; D Robinson; H J Kung; A A Ansari
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Authors:  M Torten; M Franchini; J E Barlough; J W George; E Mozes; H Lutz; N C Pedersen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection.

Authors:  Pavel Bostik; Geraldine L Dodd; Francois Villinger; Ann E Mayne; Aftab A Ansari
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  An early defect in primary and secondary T cell responses in asymptomatic cats during acute feline immunodeficiency virus (FIV) infection.

Authors:  S A Bishop; N A Williams; T J Gruffydd-Jones; D A Harbour; C R Stokes
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.